Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis
Fig 5
Meta-analysis of fasting insulin (pmol/L) in patients during CIPII treatment compared to that during control treatment (CSII).
Treatment, continuous intraperitoneal insulin infusion (CIPII); Control, continuous subcutaneous insulin infusion (CSII). Studies ordered by effect size (mean difference).